| Numéro de catalogue | HV275046 |
| Espèce hôte | Humanized |
| Reactivité des espèces | Human |
| Forme | Liquid |
| Tampon de stockage | 0.01M PBS, pH 7.4. |
| Pureté | >95% purity as determined by SDS-PAGE. |
| Clonalité | Monoclonal |
| Isotype | IgG2-kappa |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Cible | Proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9, NARC-1, PC9, Proprotein convertase 9, Neural apoptosis-regulated convertase 1, NARC1, PCSK9 |
| Purification | Protein A/G purified from cell culture supernatant. |
| Niveau d'endotoxines | Please contact the lab for this information. |
| Système d'expression | Mammalian Cells |
| Numéro d'accès | Q8NBP7 |
| Stabilité et stockage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternative name | PF-04950615, RN-316, 1407495-02-6 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Research Grade Bococizumab
Aperçu
Description
Bococizumab (HV275046) is a research-grade recombinant antibody targeting Proprotein convertase subtilisin/kexin type 9. Produced in mammalian cells with native-like glycosylation.
Highlights
- ●Research Grade — For PK/PD studies, assay development, and ADA research.
- ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Images
 SDS-PAGE |
SDS-PAGE for Research Grade Bococizumab |
 Bioactivity |
SEC-HPLC detection for Research Grade Bococizumab. |
 Bioactivity |
Detects Human PCSK9 in indirect ELISAs. Immobilized Human PCSK9, His Tag (Catalog No: HV275011) at 1 μg/mL (100 μL/well) on an Anti-His antibody (Catalog No: YP205015) Coated plate can bind Human PCSK9 Mab |